Free Twice-Weekly Pharma Manufacturing Newsletter Stay current on Biopharma Packing & Security, Supply Chain Software & Systems, and Contract Manufacturing with a twice-weekly update sent straight to your Inbox. Join more than 30,000 pharma professionals who subscribe to FiercePharmaManufacturing for FREE!
Regeneron ($REGN) has resolved concerns raised by a heritage group about traffic that will be generated by its new drug plant in Limerick, Ireland, the Limerick Leader reports. The Tarrytown, NY-based company now can proceed with its €220 million ($303 million) plans to revamp a former Dell plant there for production of drugs currently in the Eylea maker's pipeline. The drugmaker is working out sustainable transportation solutions to minimize car use for the 300 workers it expects to hire. Story | More
| Thursday, September 24th | 1pm ET / 10am PT | Sponsored by: M-Files
This webinar will discus how the emergence of the ability to share documents and data across thousands of miles instantly has pulled biopharma companies in two opposing directions. Companies want, even need, the interconnectivity that is facilitated by the Internet, but feel equally strongly about controlling who can view and interact with their data. Register today!
FiercePharmaManufacturing provides must-know news and insight on the hardware and software tools used to automate pharmaceutical manufacturing. Click here to get your free twice weekly email briefing today!